President's Advisory Council for Faith-based and Neighborhood Partnerships, 58293 [E9-27097]
Download as PDF
Federal Register / Vol. 74, No. 217 / Thursday, November 12, 2009 / Notices
A. Background
GSA Bulletin FMR B–12 was signed
on January 18, 2006, and became
effective on May 25, 2006. The Bulletin
provided a list of agencies for which
GSA granted unlimited exemptions
from the display of U.S. Government
license plates and motor vehicle
identification. 41 CFR part 102–34 was
amended on March 20, 2009 (74 FR
11870). It revised the unlimited
exemption from the requirement to
display motor vehicle identification to
exempt motor vehicles used primarily
for investigative, law enforcement,
intelligence, or security duties. The
change recognizes the need for
protecting agency missions and
occupant safety and reduces the
administrative burden of processing
exemptions while maintaining the
objective that Federal motor vehicles are
required to be conspicuously identified
unless exempted (see 40 U.S.C. 609).
Therefore, GSA is canceling this
Bulletin as unlimited exemptions are
covered in 41 CFR 102–34.175.
organizations in order to: Identify best
practices and successful modes of delivering
social services; evaluate the need for
improvements in the implementation and
coordination of public policies relating to
faith- based and other neighborhood
organizations; and make recommendations
for changes in policies, programs, and
practices.
Contact Person for Additional Information:
Mara Vanderslice, 202–260–1931,
mara.vanderslice@hhs.gov.
Supplementary Information: Please contact
Mara Vanderslice for more information about
how to join via conference call line.
Agenda: Topics to be discussed include
deliberation on draft recommendations for
Council report.
B. Procedures
Bulletins regarding motor vehicle
management are located on the Internet
at https://www.gsa.gov/fmrbulletin as
Federal Management Regulation (FMR)
bulletins.
Government-Owned Inventions;
Availability for Licensing
Dated: November 4, 2009.
James Vogelsinger,
Director, Motor Vehicle Management Policy.
[FR Doc. E9–27163 Filed 11–10–09; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
President’s Advisory Council for Faithbased and Neighborhood Partnerships
jlentini on DSKJ8SOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the President’s
Advisory Council for Faith-based and
Neighborhood Partnerships announces
the following meetings:
Name: President’s Advisory Council for
Faith-based and Neighborhood Partnerships
Council Meetings.
Times and Dates:
Tuesday, November 17th, 4 p.m. Eastern.
Tuesday, December 15th, 4 p.m. Eastern.
Tuesday, January 19th, 4 p.m. Eastern.
Place: Meetings will by conference call.
Please RSVP to receive the call-in
information.
Status: Open to the public, limited only by
the space available. Conference call line will
be available.
Purpose: The Council brings together
leaders and experts in fields related to the
work of faith-based and neighborhood
VerDate Nov<24>2008
16:12 Nov 10, 2009
Jkt 220001
Dated: November 1, 2009.
Mara Vanderslice,
Special Assistant.
[FR Doc. E9–27097 Filed 11–10–09; 8:45 am]
BILLING CODE 4154–07–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Simpler Is Better: The Production of
Young Cell Cultures From Tumor
Infiltrating Lymphocytes (TIL) Yields
More Effective Adoptive Cell Transfer
(ACT) Immunotherapies
Description of Technology: Available
for licensing is an improved method of
adoptive cell transfer (ACT)
immunotherapy that can be utilized to
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
58293
treat a variety of infectious diseases and
cancers, most notably melanoma.
At its foundation, ACT involves
isolating lymphocytes with high affinity
for a particular antigen, expanding those
cells in vitro to produce a greater
quantity of reactive cells, and infusing
the product cells into patients to attack
cells expressing the antigen, such as
tumor cells, bacterial cells, or viral
particles. Previously utilized ACT
procedures have been plagued by
technical, regulatory, and logistical
problems that have prevented
consistently successful clinical
outcomes. Through years of research,
scientists at the National Institutes of
Health (NIH) have made great strides in
developing ACT into a viable approach
to treat cancer patients. Of note, the
ACT protocols developed by NIH
scientists have successfully treated
patients with refractory metastatic
melanoma who started with very few
effective treatment options. These NIH
scientists have found that isolating cells
from the tumor infiltrating lymphocytes
(TIL) of a patient tumor sample provides
a suitable initial lymphocyte culture for
further in vitro manipulations. They
have also discovered that taking the
isolated cells through one cycle of rapid
expansion (including exposure to IL–2),
rather than multiple cycles, yields
lymphocyte cultures with higher affinity
and longer persistence in patients. Also,
they have found that administering
nonmyeloablative lymphodepleting
chemotherapy prior to the reinfusion of
lymphocytes creates a more favorable
environment within patients for the
transferred cells to execute target cell
killing. These scientists envision that,
for an ACT immunotherapy to gain
regulatory approval and successfully
treat a wide array of patients, it will
need to be rapid, reliable, and
technically simple. One of the most
critical factors to this approach is the
generation of effective lymphocyte
cultures that will rapidly and repeatedly
attack the target cells when infused into
patients.
Scientists at the NIH have developed
a method of generating CD8+ selected
‘‘young’’ lymphocyte cultures for
infusion into cancer patients.
Lymphocytes that spend fewer days in
vitro between their initial isolation from
TIL and their ultimate reinfusion into
patients compared to lymphocytes
cultured by previous ACT protocols are
considered young lymphocyte cultures.
Young lymphocytes, typically 19–35
days old when reinfused into patients,
exhibit improved proliferation, survival,
and enhanced anti-tumor activity within
patients to yield greater tumor
regression compared to older
E:\FR\FM\12NON1.SGM
12NON1
Agencies
[Federal Register Volume 74, Number 217 (Thursday, November 12, 2009)]
[Notices]
[Page 58293]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-27097]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
President's Advisory Council for Faith-based and Neighborhood
Partnerships
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the President's Advisory Council for
Faith-based and Neighborhood Partnerships announces the following
meetings:
Name: President's Advisory Council for Faith-based and
Neighborhood Partnerships Council Meetings.
Times and Dates:
Tuesday, November 17th, 4 p.m. Eastern.
Tuesday, December 15th, 4 p.m. Eastern.
Tuesday, January 19th, 4 p.m. Eastern.
Place: Meetings will by conference call. Please RSVP to receive
the call-in information.
Status: Open to the public, limited only by the space available.
Conference call line will be available.
Purpose: The Council brings together leaders and experts in
fields related to the work of faith-based and neighborhood
organizations in order to: Identify best practices and successful
modes of delivering social services; evaluate the need for
improvements in the implementation and coordination of public
policies relating to faith- based and other neighborhood
organizations; and make recommendations for changes in policies,
programs, and practices.
Contact Person for Additional Information: Mara Vanderslice,
202-260-1931, mara.vanderslice@hhs.gov.
Supplementary Information: Please contact Mara Vanderslice for
more information about how to join via conference call line.
Agenda: Topics to be discussed include deliberation on draft
recommendations for Council report.
Dated: November 1, 2009.
Mara Vanderslice,
Special Assistant.
[FR Doc. E9-27097 Filed 11-10-09; 8:45 am]
BILLING CODE 4154-07-P